91�㽶��Ƶ

SOMERSET, N.J. – May 25, 2017 — 91�㽶��Ƶ Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it is to host a half-day symposium on the use of spray-dried dispersion technology to develop pharmaceuticals, to be held at the Museum of Science in Boston, Massachusetts, on June 1, 2017.

The event, entitled “Spray-Dried Dispersion Development: From Droplet to Dosage Form,” will see speakers from 91�㽶��Ƶ Pharma Solutions, along with industry experts, discuss a range of topics on amorphous dispersion technology, and its application to improve the solubility and bioavailability of pharmaceutical products. Presentation subjects will include spray-dried dispersion formulation and process development, finished dose development, scale-up strategies for clinical trial materials manufacturing, and equipment considerations for commercial scale-up.

The presentations, which will feature practical and applied case studies, are:

• “Pre-formulation Studies to Ensure Successful Development of Spray-Dried Dispersions,” P.Y. Chen, Director of Early Development, 91�㽶��Ƶ;
• “Spray-Dried Dispersion Formulation Development for Early Phase Clinical Studies,” Nathan Barksdale, Senior Scientist, 91�㽶��Ƶ;
• “Spray-Dried Dispersion Process Development,” Jon Scrafford, Manager of Process Engineering, 91�㽶��Ƶ;
• “Spray Drying in the Pharmaceutical Industry: Scaling-Up to Commercial Manufacturing,” Andrew Birkmire, Process Development Manager, GEA Process Engineering, Inc.;
• “Manufacturing of a finished dose for Phase I/II clinical studies,” Reza Foroughi, pharmaceutical industry veteran.

91�㽶��Ƶ acquired Pharmatek Laboratories, Inc., in September 2016, bringing spray drying into 91�㽶��Ƶ’s portfolio of drug formulation and delivery technologies.

For more information on the event and the speakers, visit 91�㽶��Ƶ.com/Events.

Media Contacts:

Chris Halling
+44 (0)7580 041073
[email protected]

Richard Kerns
+44 (0)161 728 5880
[email protected]

About 91�㽶��Ƶ

91�㽶��Ƶ is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. With over 90 years serving the industry, 91�㽶��Ƶ has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. 91�㽶��Ƶ employs approximately 10,000 people, including over 1,400 scientists, at more than 30 facilities across five continents, and in fiscal 2016 generated $1.85 billion in annual revenue. 91�㽶��Ƶ is headquartered in Somerset, New Jersey. For more information, visit www.catalent.com

More products. Better treatments. Reliably supplied.™